Cargando…
SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors
OBJECTIVE: Somatostatin receptor type 5 (SST5) is inconsistently expressed by corticotroph tumors, with higher expression found in corticotropinomas having ubiquitin-specific protease 8 (USP8) mutations. Aims were to study the correlation between characteristics of corticotropinomas and SST5 express...
Autores principales: | Castellnou, Solène, Vasiljevic, Alexandre, Lapras, Véronique, Raverot, Véronique, Alix, Eudeline, Borson-Chazot, Françoise, Jouanneau, Emmanuel, Raverot, Gérald, Lasolle, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077525/ https://www.ncbi.nlm.nih.gov/pubmed/32101529 http://dx.doi.org/10.1530/EC-20-0035 |
Ejemplares similares
-
OR23-04 SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors
por: castellnou, Solene, et al.
Publicado: (2020) -
Aggressive corticotroph tumors and carcinomas
por: Lasolle, Hélène, et al.
Publicado: (2022) -
Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report
por: Lemelin, Annie, et al.
Publicado: (2019) -
Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis
por: Lasolle, Hélène, et al.
Publicado: (2020) -
Emerging and Novel Treatments for Pituitary Tumors
por: Ilie, Mirela Diana, et al.
Publicado: (2019)